#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	814	CRP	633	633	99.37	CRP.l6.c30.ctg.1	1295	33.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	454	456	ACG	44;45;45	A;C;G	44;45;45	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	814	CRP	633	633	99.37	CRP.l6.c30.ctg.1	1295	33.7	0	.	p	.	0	T209S	NONSYN	625	627	ACT	994	996	TCT	28;27;27	T;C;T	28;27;27	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	L121Q	0	.	.	361	363	CTG	314	316	CTG	121;122;122	C;T;G	120;120;119	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Q125E	0	.	.	373	375	CAG	326	328	CAG	128;129;131	C;A;G	128;125;131	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Q125R	0	.	.	373	375	CAG	326	328	CAG	128;129;131	C;A;G	128;125;131	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Q125K	0	.	.	373	375	CAG	326	328	CAG	128;129;131	C;A;G	128;125;131	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Y161C	0	.	.	481	483	TAC	434	436	TAC	149;150;148	T;A;C	148;150;148	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Y161D	0	.	.	481	483	TAC	434	436	TAC	149;150;148	T;A;C	148;150;148	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	Y161N	0	.	.	481	483	TAC	434	436	TAC	149;150;148	T;A;C	148;150;148	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	G317D	0	.	.	949	951	GGC	902	904	GGC	132;131;128	G;G;C	132;130;128	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1079	1081	GCA	113;110;110	G;C;A	110;109;110	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1079	1081	GCA	113;110;110	G;C;A	110;109;110	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1088	1090	GAA	119;120;122	G;A;A	119;120;120	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	0	HET	.	.	.	C216T	.	216	216	C	169	169	C	92	C,T	52,38	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	0	HET	.	.	.	C210T	.	210	210	C	163	163	C	96	C,T	47,49	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	0	HET	.	.	.	C99T	.	99	99	C	52	52	C	75	C,T	45,30	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	0	HET	.	.	.	C954T	.	954	954	C	907	907	C	122	C,T	56,66	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	1138	99.91	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1140	128.5	0	HET	.	.	.	T135C	.	135	135	T	88	88	T	92	T,C	48,37	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	167	3202	Escherichia_coli_EF_Tu	1185	102	96.08	Escherichia_coli_EF_Tu.l15.c17.ctg.6	102	5.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1204	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c30.ctg.1	1968	32.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1652	1654	AAA	19;18;18	A;A;A	19;18;18	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1756	Escherichia_coli_mutant	1392	1392	99.35	Escherichia_coli_mutant.l6.c30.ctg.1	1825	51.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1251	1253	GAA	80;79;80	G;A;A	80;79;80	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	372	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	903	21.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	184	G	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	173	C	171	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	156	C	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	201	T	201	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	213	C	212	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	167	C	165	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	164	A	164	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	159	A	159	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	157	A	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	147	T	146	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	147	C	147	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	157	C	157	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	156	A	156	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	152	G	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	154	C,G	152,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	161	T	161	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	226	G	226	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	247	G	247	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	254	T	252	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	193	T	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	180	G	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	152	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	145	A	142	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	156	C	153	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	154	C	152	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	77	A	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	76	A	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	70	G	69	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	129	T	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	136	G	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	60	T	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	517	200.0	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	257	C,A	255,1	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	59	G	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	A1004G	SNP	1004	1004	A	54	54	G	49	G	49	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	54	T	54	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	C1023A	SNP	1023	1023	C	73	73	A	73	A	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	T1024A	SNP	1024	1024	T	74	74	A	72	A	71	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	99	G	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4964	Pasteurella_multocida_16S	1551	143	90.91	Pasteurella_multocida_16S.l15.c17.ctg.5	143	77.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	99	T	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1314	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1601	44.0	0	.	p	.	0	H2R	NONSYN	4	6	CAT	258	260	CGT	40;40;40	C;G;T	39;39;40	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1314	PmrB_1	1092	1092	99.18	PmrB_1.l15.c30.ctg.1	1601	44.0	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1101	1103	GGC	51;51;50	G;G;C	51;51;49	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1912	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2148	47.7	0	.	p	.	0	R8S	NONSYN	22	24	AGA	241	243	AGC	14;14;13	A;G;C	14;14;13	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1912	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2148	47.7	0	.	p	.	0	I142L	NONSYN	424	426	ATA	643	645	CTA	47;50;50	C;T;A	47;50;50	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1912	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2148	47.7	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1162	1164	CAA	82;83;82	C;A;A	81;82;82	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1912	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2148	47.7	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1261	1263	GGT	69;68;68	G;G;T	69;67;68	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1912	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2148	47.7	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1831	1833	GTT	33;32;33	G;T;T	32;32;33	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	694	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1590	23.1	0	.	p	.	0	A125E	NONSYN	373	375	GCA	578	580	GAA	36;36;35	G;A;A	36;36;35	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	694	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1590	23.1	0	.	p	.	0	M185T	NONSYN	553	555	ATG	758	760	ACC	12;12;12	A;C;C	12;12;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	694	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1590	23.1	0	.	p	.	0	S225T	NONSYN	673	675	TCC	878	880	ACT	12;12;12	A;C;T	12;12;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	694	PmrE	1167	1167	96.92	PmrE.l15.c30.ctg.1	1590	23.1	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1268	1270	ATC	17;17;16	A;T;C	17;17;16	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	932	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1571	31.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3052	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3678	44.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	567	569	ATC	62;63;62	A;T;C	60;62;62	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3052	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3678	44.7	0	.	p	.	0	G549S	NONSYN	1645	1647	GGC	1959	1961	AGC	38;38;38	A;G;C	38;38;38	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	3052	acrD	3114	3114	99.07	acrD.l15.c30.ctg.1	3678	44.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2280	2282	AAG	42;42;42	A;A;G	42;42;42	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1236	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1656	40.0	0	.	p	.	0	A22V	NONSYN	64	66	GCC	322	324	GTC	17;18;16	G;T;C	17;17;16	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1236	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1656	40.0	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1063	1065	TGC	55;55;56	T;G;C	55;54;56	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	S46trunc	TRUNC	136	136	T	489	489	T	32	T	32	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	G148D	NONSYN	442	444	GGC	795	797	GAC	53;53;53	G,T;A;C	52,1;52;53	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1071	1073	TTA	38;35;34	T;T;A	37;34;34	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	2148	2150	AAT	52;52;52	A;A;T	52;52;52	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	2262	2264	AGT	52;52;55	A;G;T	52;52;55	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2661	2663	GTG	58;58;58	G;T;G	58;56;58	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	3402	acrF	3105	3105	98.78	acrF.l15.c30.ctg.1	3718	48.9	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	3216	3218	AAG	56;54;54	A;A;G	56;54;54	.	AcrF is a inner membrane transporter, similar to AcrB.;acrF
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	734	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1076	36.4	1	SNP	p	R45C	0	.	.	133	135	CGC	343	345	CGC	56;58;58	C;G;C	56;58;58	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	678	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1062	34.3	0	.	p	.	0	L34F	NONSYN	100	102	CTC	264	266	TTC	31;31;33	T;T;C	31;31;33	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	678	acrS	663	663	98.79	acrS.l15.c30.ctg.1	1062	34.3	0	.	p	.	0	E122G	NONSYN	364	366	GAG	528	530	GGG	52;53;54	G;G;G	52;53;54	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	944	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1234	40.9	0	.	p	.	0	V136L	NONSYN	406	408	GTT	622	624	CTT	60;61;60	C;T;T	60;61;60	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2718	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3202	45.8	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2130	2132	GCA	50;50;49	G;C;A,G	50;50;48,1	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2718	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3202	45.8	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2391	2393	ACC	52;51;50	A;C;C	52;50;50	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2718	alaS	2631	2631	98.94	alaS.l15.c30.ctg.1	3202	45.8	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2700	2702	GCC	42;42;43	G;C;C	42;41;43	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	G37A	NONSYN	109	111	GGT	289	291	GCT	13;13;13	G;C;T	13;13;13	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	D77E	NONSYN	229	231	GAT	409	411	GAG	11;11;10	G;A;G	11;11;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	445	447	TGC	16;16;17	T;G;C	16;16;17	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	I150V	NONSYN	448	450	ATT	628	630	GTT	22;22;22	G;T;T	22;22;22	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	R200H	NONSYN	598	600	CGC	778	780	CAC	33;31;31	C;A;C	33;31;31	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1063	1065	ATG	46;46;46	A;T;G	46;45;46	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1484	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2367	33.5	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2059	2061	CGC	38;37;38	C;G;C	38;37;38	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	756	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1301	30.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	889	891	ACC	25;25;23	A;C;C	25;25;23	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	756	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1301	30.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	901	903	TCG	22;22;24	T;C;G	22;22;24	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	662	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1166	30.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1126	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1936	31.2	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1410	1412	AAA	28;28;28	A;A;A	28;28;28	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1126	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1936	31.2	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1422	1424	GAG	21;22;21	G;A;G	20;21;21	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1126	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1936	31.2	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1428	1430	CAC	25;25;25	C;A;C	24;25;25	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	1126	baeS	1404	1404	98.86	baeS.l6.c30.ctg.1	1936	31.2	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1482	1484	GAG	25;25;25	G;A;G	25;25;25	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1510	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1922	42.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	922	cpxR	699	699	99.43	cpxR.l6.c30.ctg.1	1272	38.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	27	900	cysB	975	975	99.38	cysB.l15.c4.ctg.1	1347	35.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	996	emrA	1173	1173	98.21	emrA.l15.c30.ctg.1	1686	31.8	0	.	p	.	0	W42C	NONSYN	124	126	TGG	393	395	TGT	29;29;29	T;G;T	29;27;29	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	996	emrA	1173	1173	98.21	emrA.l15.c30.ctg.1	1686	31.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	924	926	GTC	43;44;43	G;T;C	43;43;43	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	996	emrA	1173	1173	98.21	emrA.l15.c30.ctg.1	1686	31.8	0	.	p	.	0	G234A	NONSYN	700	702	GGG	969	971	GCG	38;39;38	G;C,G;G	37;37,1;37	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	1604	emrB	1539	1539	99.81	emrB.l6.c30.ctg.1	2131	40.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	1328	emrD	1191	1191	98.57	emrD.l15.c30.ctg.1	1760	40.5	0	.	p	.	0	G209S	NONSYN	625	627	GGC	921	923	AGC	53;56;55	A;G;C	53;56;55	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	56	emrE_1	333	94	96.81	emrE_1.l15.c17.ctg.1	95	14.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	886	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1636	29.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	788	790	AGG	31;31;31	A;G;G	31;31;31	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	886	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1636	29.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1178	1180	GAC	33;33;33	G;A;C	33;33;33	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	600	emrR	531	531	100.0	emrR.l15.c30.ctg.1	962	33.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1350	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	2111	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	538	evgA	615	615	99.19	evgA.l6.c30.ctg.1	1136	25.3	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	448	450	CTG	30;31;31	C;T;G	30;31;31	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	316	318	ATA	22;22;21	A;T;A	22;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	328	330	GTA	16;19;20	G;T;A	15;19;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	481	483	ACG	21;23;23	A;C;G	21;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	544	546	GAA	20;20;20	G;A;A	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	583	585	GCT	21;22;22	G;C;T	21;21;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	601	603	GAT	21;22;22	G;A;T	21;22;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	688	690	TCA	24;23;21	T;C;A	24;23;21	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	817	819	CAG	18;17;16	C;A;G	18;17;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	955	957	GTT	20;18;19	G;T;T	20;18;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1111	1113	GAT	16;18;18	G;A;T	16;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1279	1281	AAT	28;27;27	A;A;T	28;27;27	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1300	1302	TTA	18;17;17	T;T;A	18;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1501	1503	AAA	29;29;29	A;A;A	28;29;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2236	2238	CAT	31;31;32	C;A;T	31;31;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2290	2292	CAT	32;31;31	C;A;T	32;31;31	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2308	2310	AGA	37;37;35	A;G;A	37;37;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2323	2325	AAT	36;35;35	A;A;T	36;35;35	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2470	2472	TCC	26;25;28	T;C;C	26;25;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2635	2637	ATT	36;37;33	A;T;T	36;37;33	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2656	2658	GAT	38;38;36	G;A;T	38;38;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2770	2772	GTT	34;35;34	G;T;T	33;35;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3055	3057	CAC	30;30;30	C;A;C	30;29;30	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2646	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4115	34.5	0	.	p	.	0	D1197N	NONSYN	3589	3591	GAC	3793	3795	AAC	25;24;24	A;A;C	25;24;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	962	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1379	37.5	1	SNP	p	P64H	0	.	.	190	192	CCA	457	459	CCA	72;72;74	C;C;A	72;71;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	962	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1379	37.5	1	SNP	p	P64A	0	.	.	190	192	CCA	457	459	CCA	72;72;74	C;C;A	72;71;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	962	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1379	37.5	1	SNP	p	P64S	0	.	.	190	192	CCA	457	459	CCA	72;72;74	C;C;A	72;71;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	962	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1379	37.5	1	SNP	p	P64R	0	.	.	190	192	CCA	457	459	CCA	72;72;74	C;C;A	72;71;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	962	folP_1	849	849	99.29	folP_1.l15.c30.ctg.1	1379	37.5	1	SNP	p	P64L	0	.	.	190	192	CCA	457	459	CCA	72;72;74	C;C;A	72;71;69	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	630	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1152	29.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	425	95.29	gadW.l15.c4.ctg.1	526	14.3	0	.	p	.	0	K110N	NONSYN	328	330	AAA	30	32	AAT	7;7;7	A;A;T	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	425	95.29	gadW.l15.c4.ctg.1	526	14.3	0	.	p	.	0	S234A	NONSYN	700	702	TCG	402	404	GCG	13;15;15	G;C;G	13;15;15	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	L31V	NONSYN	91	93	CTG	10	12	GTG	2;2;2	G;T;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	D34E	NONSYN	100	102	GAT	19	21	GAG	2;2;2	G;A;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	L46P	NONSYN	136	138	CTG	55	57	CCG	4;4;4	C;C;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	E54D	NONSYN	160	162	GAA	79	81	GAT	7;7;7	G;A;T	7;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	I88M	NONSYN	262	264	ATA	181	183	ATG	8;7;7	A;T;G	8;7;7	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	513	164	gadW	729	218	93.58	gadW.l15.c4.ctg.2	220	4.9	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	184	186	CCG	7;6;6	C;C;G	7;6;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	634	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1225	27.7	0	.	p	.	0	F53L	NONSYN	157	159	TTC	342	344	TTA	24;24;23	T;T;A	24;24;23	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	634	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1225	27.7	0	.	p	.	0	V79I	NONSYN	235	237	GTT	420	422	ATT	35;35;34	A;T;T	35;35;33	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	634	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1225	27.7	0	.	p	.	0	R246G	NONSYN	736	738	AGA	921	923	GGA	29;30;31	G;G;A	29;30;31	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	634	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1225	27.7	0	.	p	.	0	S248P	NONSYN	742	744	TCG	927	929	CCG	25;25;25	C;C;G	25;25;25	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2339	2341	GAA	37;36;37	G;A;A	37;36;36	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	S83I	0	.	.	247	249	TCG	554	556	TCG	57;55;56	T;C;G	55;55;56	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	S83W	0	.	.	247	249	TCG	554	556	TCG	57;55;56	T;C;G	55;55;56	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	S83L	0	.	.	247	249	TCG	554	556	TCG	57;55;56	T;C;G	55;55;56	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	D87N	0	.	.	259	261	GAC	566	568	GAC	55;56;56	G;A;C	54;56;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	D87G	0	.	.	259	261	GAC	566	568	GAC	55;56;56	G;A;C	54;56;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	D87H	0	.	.	259	261	GAC	566	568	GAC	55;56;56	G;A;C	54;56;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	D87Y	0	.	.	259	261	GAC	566	568	GAC	55;56;56	G;A;C	54;56;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2504	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3233	41.6	1	SNP	p	D87V	0	.	.	259	261	GAC	566	568	GAC	55;56;56	G;A;C	54;56;55	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136H	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136G	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136C	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136E	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136S	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136L	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2958	gyrB_1	2415	2415	99.13	gyrB_1.l6.c4.ctg.1	2957	53.7	1	SNP	p	R136I	0	.	.	406	408	CGC	683	685	CGC	64;63;62	C;G;C	63;63;62	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	520	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1117	24.9	0	.	p	.	0	A72P	NONSYN	214	216	GCG	475	477	CCG	32;30;32	C;C;G	32;30;32	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	520	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1117	24.9	0	.	p	.	0	T123A	NONSYN	367	369	ACC	628	630	GCC	22;22;22	G;C;C	22;22;22	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	1008	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1399	38.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	225	227	TCA	33;34;36	T;C;A	33;34;36	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	332	marA	384	384	99.74	marA.l6.c30.ctg.1	926	19.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	555	557	AGC	14;12;14	A;G;C	14;12;14	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	657	659	CAT	9;9;9	C;A;T	7;7;9	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	V45E	0	.	.	133	135	GTG	381	383	GTG	33;33;34	G;T;G	33;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	I49S	0	.	.	145	147	ATC	393	395	ATC	34;35;35	A;T;C	34;35;35	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	A70T	0	.	.	208	210	GCA	456	458	GCA	33;33;34	G;C;A	33;33;34	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R73S	0	.	.	217	219	CGT	465	467	CGT	34;33;33	C;G;T	34;32;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R73C	0	.	.	217	219	CGT	465	467	CGT	34;33;33	C;G;T	34;32;33	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R77L	0	.	.	229	231	CGC	477	479	CGC	29;29;28	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R77C	0	.	.	229	231	CGC	477	479	CGC	29;29;28	C;G;C	29;29;28	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	L78M	0	.	.	232	234	CTG	480	482	CTG	28;29;29	C;T;G	28;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R94S	0	.	.	280	282	CGC	528	530	CGC	14;14;14	C;G;C	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	R94H	0	.	.	280	282	CGC	528	530	CGC	14;14;14	C;G;C	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	256	marR	435	435	97.7	marR.l15.c30.ctg.1	899	15.2	1	SNP	p	V96E	0	.	.	286	288	GTA	534	536	GTA	15;13;13	G;T;A	15;13;13	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	4	6	TTC	2;2;2	T;T;C	2;2;2	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	91	93	ATC	15;15;15	A;T;C	15;15;15	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	109	111	GCC	8;8;8	G;C;C	8;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	112	114	GTG	8;8;8	G;T;G	8;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	139	141	GAT	6;6;6	G;A;T	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	160	162	ACC	4;4;4	A;C;C	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	187	189	TTA	11;11;11	T;T;A	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	328	330	CAG	45;45;46	C;A;G	45;45;45	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	367	369	GCC	32;34;34	G;C;C	32;34;34	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	472	474	GCG	33;34;36	G;C;G	33;34;36	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	676	678	GTT	35;36;36	G;T;T	28;31;31	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	862	mdfA	1233	1218	96.96	mdfA.l15.c17.ctg.1	1368	33.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	838	838	C	43	C	43	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	946	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1711	29.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	224	224	G	39	G	39	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	946	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1711	29.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	281	283	CAG	21;23;23	C;A;G	21;23;23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	946	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1711	29.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	431	433	ATC	26;24;23	A;T;C	26;24;23	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	946	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1711	29.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	479	481	ATG	23;25;25	A;T;G	23;25;25	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	946	mdtA	1248	1248	97.44	mdtA.l6.c17.ctg.1	1711	29.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	572	574	ACC	26;27;26	A;C;C	26;27;26	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2049	2051	ACC	56;56;58	A;C;C	55;56;58	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2442	2444	CAA	40;41;41	C;A;A	39;41;41	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2610	2612	ATT	44;44;44	A;T;T	44;44;44	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2694	2696	GTT	43;43;42	G;T;T	43;43;42	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2802	2804	GAG	46;46;46	G;A;G	46;46;46	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3030	3032	ATG	43;43;42	A;T;G	42;43;42	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	3240	mdtB	3123	3123	98.94	mdtB.l15.c30.ctg.1	3684	47.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3165	3167	GAT	55;56;58	G;A;T	53;55;58	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2952	mdtC	3078	3078	98.7	mdtC.l6.c30.ctg.1	3562	44.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	389	391	ATG	31;32;33	A;T;G	31;32;33	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2952	mdtC	3078	3078	98.7	mdtC.l6.c30.ctg.1	3562	44.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	875	877	ATC	57;57;56	A;T;C	57;57;56	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2952	mdtC	3078	3078	98.7	mdtC.l6.c30.ctg.1	3562	44.5	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3191	3193	CAC	17;17;17	C;A;C	16;17;15	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1358	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1889	38.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	192	194	GAA	14;14;14	G;A;A	14;14;14	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1358	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1889	38.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	861	863	GCG	45;42;43	G;C;G	45;40;43	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1358	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1889	38.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1203	1205	ATC	55;54;56	A;T;C	55;54;56	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1358	mdtD	1416	1416	98.38	mdtD.l15.c4.ctg.1	1889	38.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1506	1508	TTT	54;53;51	T;T;T	53;53;51	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1460	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1766	44.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3522	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3580	52.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1141	1143	ACC	31;32;33	A;C;C	31;31;33	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	3522	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3580	52.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2383	2385	GAC	52;52;53	G;A;C	52;52;52	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1152	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1531	34.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	693	695	ATC	37;34;37	A;T;C	36;34;37	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1152	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	471	18.2	0	.	p	.	0	E5G	NONSYN	13	15	GAA	150	152	GGA	17;18;18	G;G;A	17;18;18	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1002	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1624	33.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	590	592	TGT	45;44;43	T;G;T	45;44;43	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1002	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1624	33.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1160	1162	TTG	38;39;38	T;T;G	38;38;38	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	1002	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1624	33.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1370	1372	ACG	9;9;9	A;C;G	9;9;9	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	1288	mdtL	1176	1176	98.21	mdtL.l6.c30.ctg.1	1807	38.4	0	.	p	.	0	A185S	NONSYN	553	555	GCC	894	896	TCC	30;29;29	T;C;C	28;28;28	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1054	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1490	37.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	613	615	ATT	30;29;30	A;T;T	30;29;30	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	V11M	NONSYN	31	33	GTG	218	220	ATG	27;29;29	A;T;G	27;29;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	T33I	NONSYN	97	99	ACC	284	286	ATC	27;26;27	A;T;C	27;26;27	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	C116R	NONSYN	346	348	TGC	533	535	CGC	62;61;60	C;G;C	61;61;59	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	N238S	NONSYN	712	714	AAC	899	901	AGC	47;47;47	A;G;C	47;47;46	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1100	1102	GTG	28;28;28	G;T;G	27;27;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1163	1165	AAC	25;25;26	A;A;C	23;23;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1208	1210	GTC	50;49;49	G;T;C	50;46;49	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1238	1240	ATA	42;42;41	A;T;A	42;42;40	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1346	1348	TCT	34;35;35	T;C;T	34;35;35	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1733	1735	GCG	53;52;55	G;C;G	52;51;55	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1946	1948	ATC	59;57;56	A;T;C	59;57;56	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	2032	mdtO	2052	2052	98.05	mdtO.l15.c30.ctg.1	2536	42.9	0	.	p	.	0	T626S	NONSYN	1876	1878	ACC	2063	2065	AGC	50;49;48	A;G;C	48;49;46	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	Q68trunc	TRUNC	202	202	C	531	531	T	68	T	67	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	714	716	GCG	46;42;40	G;C;G	46;42;39	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	888	890	ACC	58;59;57	A;C;C	57;56;56	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	960	962	CGC	61;58;58	C;G;C	61;58;58	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1077	1079	GCT	42;42;43	G;C;T	42;42;42	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1161	1163	AAA	31;29;29	A;A;A	30;29;29	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1179	1181	CGA	30;31;32	C;G;A	29;31;31	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1344	1346	GCC	35;34;34	G;C;C	35;34;34	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1356	1358	GAT	33;36;36	G;A;T	33;36;36	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	531	1446	mdtP	1467	1467	97.89	mdtP.l15.c17.ctg.1	2084	37.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1773	1775	GCT	19;18;17	G;C;T	19;18;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3044	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3882	42.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1512	1514	AAG	26;25;26	A;A;G	26;25;26	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	3044	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3882	42.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2589	2591	CTG	46;46;46	C;T;G	46;44;46	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	192	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	669	15.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1650	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2274	39.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1088	1090	AAC	39;38;38	A;A;C	39;37;38	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1650	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2274	39.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1634	1636	ATA	42;43;42	A;T;A	42;43;42	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1386	murA_12	1260	1260	98.57	murA_12.l6.c30.ctg.1	1841	40.4	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1431	1433	GAT	68;67;66	G;A;T	68;67;66	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1386	murA_12	1260	1260	98.57	murA_12.l6.c30.ctg.1	1841	40.4	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1434	1436	CTG	67;66;66	C;T;G	66;65;65	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	381	383	TGT	27;27;29	T;G;T	27;27;29	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	651	653	ACC	51;49;50	A;C;C	51;49;50	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	861	863	GAC	34;34;34	G;A;C	34;34;34	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	1	SNP	p	R15C	0	.	.	43	45	CGC	345	347	CGC	42;41;40	C;G;C	42;39;40	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	1	SNP	p	S33R	0	.	.	97	99	AGC	399	401	AGC	32;31;31	A;G;C	32;31;31	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	1	SNP	p	G131D	0	.	.	391	393	GGC	693	695	GGC	44;44;45	G;G;C	44;44;42	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	1	SNP	p	R203C	0	.	.	607	609	CGT	909	911	CGT	40;40;41	C;G;T	40;40;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	604	nfsA	723	723	99.03	nfsA.l6.c17.ctg.1	1296	25.0	1	SNP	p	R203L	0	.	.	607	609	CGT	909	911	CGT	40;40;41	C;G;T	40;40;41	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1144	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1690	36.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1192	1194	GAG	38;40;39	G;A;G	38;40;39	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1144	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1690	36.4	1	SNP	p	G141E	0	.	.	421	423	GGT	679	681	GGT	61;61;59	G;G;T	61;61;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1144	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1690	36.4	1	SNP	p	G141D	0	.	.	421	423	GGT	679	681	GGT	61;61;59	G;G;T	61;61;59	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1144	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1690	36.4	1	SNP	p	R154A	0	.	.	460	462	CGT	718	720	CGT	56;56;55	C;G;T	56;56;55	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1144	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1690	36.4	1	SNP	p	R154D	0	.	.	460	462	CGT	718	720	CGT	56;56;55	C;G;T	56;56;55	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2740	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2713	54.0	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1887	1889	TCG	71;71;71	T;C;G	69;70;70	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2740	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2713	54.0	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2502	2504	AAC	36;36;35	A;A;C	36;36;35	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2740	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2713	54.0	1	SNP	p	A85T	0	.	.	253	255	GCG	516	518	GCG	48;47;48	G;C;G	48;47;48	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2740	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2713	54.0	1	SNP	p	D111H	0	.	.	331	333	GAT	594	596	GAT	61;59;59	G;A;T	61;58;59	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2740	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2713	54.0	1	SNP	p	S129P	0	.	.	385	387	TCC	648	650	TCC	52;53;53	T;C,A;C	52;52,1;52	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	27	1708	parE_1	1893	1893	97.57	parE_1.l15.c30.ctg.1	2345	38.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1653	1655	GAT	68;69;69	G;A;T	68;69;69	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1662	patA	1380	1380	99.86	patA.l15.c30.ctg.1	1920	46.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1355	1357	GAT	63;64;63	G;A;T	63;62;61	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	V146F	0	.	.	436	438	GTT	725	727	GTT	78;78;76	G;T;T	78;78;75	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1826	1828	CAG	72;73;74	C;A;G	72;73;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1826	1828	CAG	72;73;74	C;A;G	72;73;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1865	1867	CAC	76;76;77	C;A;C	76;76;77	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1874	1876	CGT	76;75;74	C;G;T	76;75;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1874	1876	CGT	76;75;74	C;G;T	76;75;74	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1880	1882	TCC	71;68;68	T;C;C	70;68;68	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1886	1888	CTC	62;62;59	C;T;C	62;61;59	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1976	1978	ACC	56;55;51	A;C;C	56;55;51	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1979	1981	CCT	51;48;47	C;C;T	51;48;47	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	5058	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4631	58.7	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2348	2350	CGT	72;69;67	C;G;T	72;69;66	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	.	n	.	0	A226G	SNP	226	226	A	388	388	G	451	G	451	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	A794G	0	.	.	794	794	A	956	956	A	441	A	436	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	A794T	0	.	.	794	794	A	956	956	A	441	A	436	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	G926C	0	.	.	926	926	G	1088	1088	G	440	G,C	438,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	G926T	0	.	.	926	926	G	1088	1088	G	440	G,C	438,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	G926A	0	.	.	926	926	G	1088	1088	G	440	G,C	438,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	A1519G	0	.	.	1519	1519	A	1681	1681	A	261	A,C	259,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	A1519C	0	.	.	1519	1519	A	1681	1681	A	261	A,C	259,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	1	SNP	n	A1519T	0	.	.	1519	1519	A	1681	1681	A	261	A,C	259,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	C194T	.	194	194	C	356	356	C	439	C,T	340,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	G474A	.	474	474	G	636	636	G	409	G,A	335,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	G1002A	.	1002	1002	G	1164	1164	G	430	G,A	266,164	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	G1006C	.	1006	1006	G	1168	1168	G	436	G,C	268,157	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	A79G,C	.	79	79	A	241	241	A	374	A,G,C	269,102,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	C719T	.	719	719	C	881	881	C	404	C,T	240,160	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	T273A	.	273	273	T	435	435	T	384	T,A	290,91	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	T1010C	.	1010	1010	T	1172	1172	T	422	T,C	259,158	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	A250T	.	250	250	A	412	412	A	386	A,T	287,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	C1038T	.	1038	1038	C	1200	1200	C	406	C,T	255,148	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	C183T,A	.	183	183	C	345	345	C	419	C,T,A	275,141,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	T90C	.	90	90	T	252	252	T	369	T,C	272,96	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	13742	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1718	405.6	0	HET	.	.	.	A253T	.	253	253	A	415	415	A	381	A,T	282,97	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	640	soxR	465	465	100.0	soxR.l15.c4.ctg.1	956	35.5	1	SNP	p	R20H	0	.	.	58	60	CGC	336	338	CGC	52;50;51	C;G;C	52;50;51	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	640	soxR	465	465	100.0	soxR.l15.c4.ctg.1	956	35.5	1	SNP	p	G121D	0	.	.	361	363	GGT	639	641	GGT	56;56;57	G;G;T	56;56;57	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	510	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	975	28.0	1	SNP	p	A12S	0	.	.	34	36	GCA	406	408	GCA	61;61;62	G;C;A	61;61;62	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1744	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	2064	45.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
